Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001214659-25-004427
Filing Date
2025-03-17
Accepted
2025-03-17 06:04:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 8748
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 465677
  Complete submission text file 0001214659-25-004427.txt   476444
Mailing Address 870 MARKET STREET ROOM 415 SAN FRANCISCO CA 94102
Business Address 870 MARKET STREET ROOM 415 SAN FRANCISCO CA 94102 (650) 938-6300
23andMe Holding Co. (Subject) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
Type: SCHEDULE 13D | Act: 34 | File No.: 005-91734 | Film No.: 25742216
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 65 CHULIA STREET #45-04 OCBC CENTRE SINGAPORE U0 049513
Business Address 65 CHULIA STREET #45-04 OCBC CENTRE SINGAPORE U0 049513 6566351950
Zentree Investments Ltd (Filed by) CIK: 0001946012 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: SCHEDULE 13D